Cathie Wood’s ARK Invest Buys Over 675,000 More Shares of CRISPR
A couple of Cathie Wood's ARK Invest exchange-traded funds bought over 675,000 shares of CRISPR Therapeutics on October 14.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
A couple of ARK Invest funds run by ETF star Cathie Wood made a huge buy on Wednesday. Specifically, these exchange-traded funds bought roughly $65 million worth of CRISPR Therapeutics AG (NASDAQ: CRSP | CRSP Price Prediction), as the prices of these funds were fairly positive on Wednesday. Note that their performance is mixed in the past year.
[in-text-ad]
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 150,210 shares of CRISPR, and ARK Innovation ETF (NYSEARCA: ARKK) bought 527,747 shares. At Wednesday’s closing prices, this would have valued the sales at roughly $65.6 million altogether. Even though this is a small fraction of their total holdings, every little bit counts. The innovation ETF is up about 10% and the other is down 1% in the past year.
Note that these same funds also purchased nearly $40 million in CRISPR shares earlier this week.
[nativounit]
Check out all the ARK Invest trades for Wednesday as well:
| Fund | Direction | Ticker | Name | Shares |
|---|---|---|---|---|
| ARKG | Buy | CRSP | CRISPR THERAPEUTICS | 150,210 |
| ARKG | Buy | DYNS | DYNAMICS SPECIAL PURPOSE | 577 |
| ARKG | Buy | NTLA | INTELLIA THERAPEUTICS | 51,559 |
| ARKG | Buy | QSI | QUANTUM-SI | 19,900 |
| ARKG | Buy | SLGC | SOMALOGIC | 399,610 |
| ARKG | Buy | VCYT | VERACYTE | 11,037 |
| ARKG | Sell | VEEV | VEEVA SYSTEMS | 81,531 |
| ARKK | Buy | CRSP | CRISPR THERAPEUTICS | 527,747 |
| ARKK | Buy | BEAM | BEAM THERAPEUTICS | 18,429 |
| ARKK | Sell | PRLB | PROTO LABS | 119,571 |
| ARKK | Sell | SPOT | SPOTIFY TECHNOLOGY | 128,790 |
| ARKK | Sell | U | UNITY SOFTWARE | 142,810 |
| ARKQ | Buy | MKFG | MARKFORGED | 127,526 |
| ARKQ | Buy | TWOU | 2U | 1,330 |
| ARKQ | Buy | VLD | VELO3D | 102,790 |
| ARKW | Buy | GENI | GENIUS SPORTS | 21,618 |
| ARKX | Buy | MKFG | MARKFORGED | 199,719 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
[recirclink id=971834][wallst_email_signup]
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
